www.paion.com
Open in
urlscan Pro
134.119.0.208
Public Scan
Submitted URL: http://paion.de/
Effective URL: https://www.paion.com/
Submission: On November 07 via api from US — Scanned from DE
Effective URL: https://www.paion.com/
Submission: On November 07 via api from US — Scanned from DE
Form analysis 1 forms found in the DOM
<form action="" class="cc-data">
<div class="cc-center">
<h3 class="blue">This website uses cookies.</h3>
<p>Some of them are essential and required for running the website. Others improve your user experience and may be activated or deactivated at your discretion.</p>
</div>
<ul class="cookie-box__list">
<li>
<label for="checkbox-essential" class="_c-checkbox">
<input id="checkbox-essential" type="checkbox" name="cc-essential" value="essential" checked="" disabled=""> essential </label>
</li>
<li>
<label for="checkbox-analytics" class="_c-checkbox">
<input id="checkbox-analytics" type="checkbox" name="cc-analytics" value="analytics"> statistics </label>
</li>
<li>
<label for="checkbox-extmedia" class="_c-checkbox">
<input id="checkbox-extmedia" type="checkbox" name="cc-extmedia" value="extmedia"> external media </label>
</li>
</ul>
<div class="d-flex flex-column">
<a class="btn btn-large btn-primary d-block m-2" id="accept-all">Accept all</a>
<a class="btn btn-light btn-sm btn-secondary d-block m-2" id="cc-save">Save</a>
<div>
<div class="cookie-footer">
<a class="btn btn-sm m-2" href="/footernav/datenschutzerklaerung/">Privacy Statement</a>
<a class="btn btn-sm m-2" href="/footernav/impressum/">Imprint</a>
</div>
</div>
</div>
</form>Text Content
en de
*
* Company
ABOUT PAION
History
Management
Supervisory Board
INFORMATION
Events
Information Request
* Products
REMIMAZOLAM
About Remimazolam
UK SMPC for remimazolam
UK PIL for remimazolam
ANGIOTENSIN II
About Angiotensin II
ERAVACYCLINE
About eravacycline
* Career
WHAT DOES PAIONEERING MEAN TO US?
WHAT PAIONEERS CAN EXPECT
Professional Development
JOB OFFERS
* Media and Investors
AT A GLANCE
General Information
Contact
NEWSROOM
Press Releases
Ad-hoc Releases
Directors' Dealings
Holdings in company
INFORMATION ON SHARES
Chart & Fact sheet
Analysts
Capital actions
Information on CeNeS Acquisition
INVESTORCENTER
Financial Reports
Presentations
Corporate calendar
Information Request
CORPORATE GOVERNANCE
Declaration on Corporate Governance
Articles of Association
Declaration of Conformity
Code of Conduct
By-Laws Supervisory Board
Compensation Management Board and Supervisory Board
ANNUAL GENERAL MEETING
2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
* Contact
GERMANY
UK
NORDIC COUNTRIES
NETHERLANDS
*
prev next
OUR MISSION
PAION’s mission is to be a leading specialty pharmaceutical company in the
fields of anesthesia and critical care by bringing novel products to market to
benefit patients, doctors and other stakeholders in healthcare.
H1 2022
TELECONFERENCE & WEBCAST
31 August 2022
Replay
NEWS
08/31/2022
PAION AG REPORTS FINANCIAL RESULTS FOR THE FIRST HALF-YEAR 2022
DGAP-News: PAION AG / Key word(s): Half Year Results PAION AG...
Read more
08/31/2022
CONSOLIDATED FINANCIAL INTERIM REPORT FOR THE FIRST HALF YEAR 2022
Consolidated Financial Interim Report for the First Half-Year...
Read more
08/01/2022
PAION LAUNCHES ERAVACYCLINE FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL...
DGAP-News: PAION AG / Key word(s): Market Launch PAION LAUNCHES...
Read more
To the newsroom
PAION CHART
Load Chart
I consent to the display of external content. This enables personal data to be
transmitted to third-party platforms. Read more about our privacy policy.
VISIT US ON LINKEDIN!
* copyright © 2022 PAION AG I all rights reserved
* Imprint
* Privacy Statement
* General Terms and Conditions
Heussstraße 25 | 52078 Aachen | Deutschland
Tel.: +49 241 4453-0 | Fax.: +49 241 4453-100 | e-mail: info@paion.com
COMPANY
1. About PAION +
History
Management
Supervisory Board
2. Information +
Events
Information Request
PRODUCTS
1. Remimazolam +
About Remimazolam
UK SMPC for remimazolam
UK PIL for remimazolam
2. Angiotensin II +
About Angiotensin II
3. Eravacycline +
About eravacycline
CAREER
1. What does PAIONeering mean to us?
2. What PAIONeers can expect +
Professional Development
3. Job offers
MEDIA AND INVESTORS
1. At a glance +
General Information
Contact
2. Newsroom +
Press Releases
Ad-hoc Releases
Directors' Dealings
Holdings in company
3. Information on shares +
Chart & Fact sheet
Analysts
Capital actions
Information on CeNeS Acquisition
4. Investorcenter +
Financial Reports
Presentations
Corporate calendar
Information Request
5. Corporate Governance +
Declaration on Corporate Governance
Articles of Association
Declaration of Conformity
Code of Conduct
By-Laws Supervisory Board
Compensation Management Board and Supervisory Board
6. Annual general meeting +
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
CONTACT
1. Germany
2. UK
3. Nordic Countries
4. Netherlands
Cookie Settings
THIS WEBSITE USES COOKIES.
Some of them are essential and required for running the website. Others improve
your user experience and may be activated or deactivated at your discretion.
* essential
* statistics
* external media
Accept all Save
Privacy Statement Imprint